{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:58:37Z","timestamp":1770825517660,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Netherlands Institute of Regenerative Medicine"},{"name":"NanoNext.NL"},{"name":"EU ERC Advanced Grant FIBROIMAGING"},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1066"],"award-info":[{"award-number":["SFB1066"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jconrel.2018.12.039","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T13:31:09Z","timestamp":1548250269000},"page":"250-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The antifibrotic potential of a sustained release formulation of a PDGF\u03b2-receptor targeted rho kinase inhibitor"],"prefix":"10.1016","volume":"296","author":[{"given":"F.","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Teekamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.O.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zuidema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Steendam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias H.M.","family":"Klose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel M.","family":"Meier-Menches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Casini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.L.","family":"Horvatovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.","family":"Sijbrandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.L.J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Beljaars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Olinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.jconrel.2018.12.039_bb0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.jconrel.2018.12.039_bb0010","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jconrel.2018.12.039_bb0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-2007-1007126","article-title":"Liver microvascular architecture: an insight into the pathophysiology of portal hypertension","volume":"19","author":"Ekataksin","year":"1999","journal-title":"Semin. Liver Dis."},{"issue":"6","key":"10.1016\/j.jconrel.2018.12.039_bb0020","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jhep.2012.07.033","article-title":"HSC-specific inhibition of rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects","volume":"57","author":"Klein","year":"2012","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.jconrel.2018.12.039_bb0025","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gut.2005.081059","article-title":"Intrahepatic upregulation of RhoA and rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis","volume":"55","author":"Zhou","year":"2006","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.jconrel.2018.12.039_bb0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cm.20472","article-title":"Rho-kinase\/ROCK: a key regulator of the cytoskeleton and cell polarity","volume":"67","author":"Amano","year":"2010","journal-title":"Cytoskeleton (Hoboken)"},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.039_bb0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/jpet.111.179143","article-title":"Reduction of fibrogenesis by selective delivery of a rho kinase inhibitor to hepatic stellate cells in mice","volume":"337","author":"van Beuge","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.039_bb0040","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1053\/j.gastro.2005.11.029","article-title":"Defective RhoA\/rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats","volume":"130","author":"Hennenberg","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jconrel.2018.12.039_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0168-8278(00)00059-3","article-title":"A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"34","author":"Tada","year":"2001","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.039_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0022-4804(03)00202-6","article-title":"Therapeutic significance of Y-27632, a rho-kinase inhibitor, on the established liver fibrosis","volume":"114","author":"Murata","year":"2003","journal-title":"J. Surg. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2018.12.039_bb0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0168-8278(01)00169-6","article-title":"Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells","volume":"35","author":"Murata","year":"2001","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.jconrel.2018.12.039_bb0060","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2106","article-title":"Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition","volume":"7","author":"Force","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.jconrel.2018.12.039_bb0065","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jconrel.2018.12.039_bb0070","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Beljaars","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.12.039_bb0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2017.11.029","article-title":"Pharmacokinetics of a sustained release formulation of PDGFbeta-receptor directed carrier proteins to target the fibrotic liver","volume":"269","author":"van Dijk","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.039_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.106.106054","article-title":"Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular cells: a novel strategy to treat renal fibrosis","volume":"319","author":"Prakash","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.jconrel.2018.12.039_bb0085","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1681\/ASN.2007070794","article-title":"Inhibition of renal rho kinase attenuates ischemia\/reperfusion-induced injury","volume":"19","author":"Prakash","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.039_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF03190201","article-title":"Pharmacokinetic characterization of controlled-release formulations","volume":"15","author":"Steinijans","year":"1990","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.039_bb0095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1517\/17425247.2015.961420","article-title":"Long-term delivery of protein therapeutics","volume":"12","author":"Vaishya","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2018.12.039_bb0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2017.09.072","article-title":"Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGFbeta-receptor in the fibrotic kidney","volume":"534","author":"Teekamp","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.039_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1525-1578(10)60455-2","article-title":"Analysis of microarray data using Z score transformation","volume":"5","author":"Cheadle","year":"2003","journal-title":"J. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.jconrel.2018.12.039_bb0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000445269","article-title":"New developments on the treatment of liver fibrosis","volume":"34","author":"Koyama","year":"2016","journal-title":"Dig. Dis."},{"issue":"5","key":"10.1016\/j.jconrel.2018.12.039_bb0115","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1046\/j.1523-1755.2002.00328.x","article-title":"Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction","volume":"61","author":"Nagatoya","year":"2002","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.jconrel.2018.12.039_bb0120","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/labinvest.2008.71","article-title":"Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury","volume":"88","author":"Borkham-Kamphorst","year":"2008","journal-title":"Lab. Investig."},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.039_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2010.03.018","article-title":"A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier","volume":"145","author":"Prakash","year":"2010","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.039_bb0130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11095-006-9175-2","article-title":"Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated","volume":"24","author":"Hagens","year":"2007","journal-title":"Pharm. Res."},{"issue":"142A","key":"10.1016\/j.jconrel.2018.12.039_bb0135","article-title":"Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects","volume":"66","author":"Magdaleno","year":"2017","journal-title":"Hepatology"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2018.12.039_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1011083429704","article-title":"Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum","volume":"219","author":"Ikeda","year":"2001","journal-title":"Mol. Cell. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2018.12.039_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2005.12.010","article-title":"Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology","volume":"111","author":"Gonzalo","year":"2006","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.039_bb0150","first-page":"942","article-title":"Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats","volume":"51","author":"Moreno","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.039_bb0155","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/jpet.106.114496","article-title":"Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells","volume":"321","author":"Gonzalo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2018.12.039_bb0165","series-title":"Microspheres for Local Drug Delivery (Doctoral Thesis)","author":"Zandstra","year":"2016"},{"issue":"2","key":"10.1016\/j.jconrel.2018.12.039_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/dmm.012062","article-title":"Diverse functions of matrix metalloproteinases during fibrosis","volume":"7","author":"Giannandrea","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"1","key":"10.1016\/j.jconrel.2018.12.039_bb0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCRESAHA.112.266882","article-title":"Membrane-associated matrix proteolysis and heart failure","volume":"112","author":"Spinale","year":"2013","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2018.12.039_bb0180","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.510300431","article-title":"Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation","volume":"30","author":"Benyon","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jconrel.2018.12.039_bb0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.200109100","article-title":"The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1","volume":"157","author":"Mu","year":"2002","journal-title":"J Cell Biol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918307442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918307442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T20:40:45Z","timestamp":1565210445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918307442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":36,"alternative-id":["S0168365918307442"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.039","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antifibrotic potential of a sustained release formulation of a PDGF\u03b2-receptor targeted rho kinase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}